Candriam Equities L Biotech.V2 USD Acc/ LU2026682919 /
| NAV2024-04-25 | Chg.-19.6000 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 1,723.8101USD | -1.12% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | - | - | - | - | - | 0.79 | -2.58 | 9.54 | 3.06 | - |
| 2021 | 1.89 | -2.53 | -4.20 | 2.79 | -2.19 | 6.44 | -1.39 | 3.98 | -4.17 | 0.23 | -4.31 | 2.49 | -1.66% |
| 2022 | -10.51 | -1.49 | 6.13 | -7.16 | -3.90 | 3.59 | 4.79 | 1.62 | -1.83 | 6.58 | 6.26 | -2.79 | -0.47% |
| 2023 | 3.00 | -5.59 | 0.33 | 2.35 | -0.85 | 1.51 | -0.49 | -0.14 | -4.41 | -6.03 | 6.25 | 13.72 | +8.38% |
| 2024 | 1.58 | 1.43 | 0.05 | -7.33 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 15.79% | 18.53% | 16.13% | 20.11% | -% |
| Sharpe ratio | -1.11 | 1.42 | -0.05 | -0.16 | - |
| Best month | +13.72% | +13.72% | +13.72% | +13.72% | - |
| Worst month | -7.33% | -7.33% | -7.33% | -10.51% | - |
| Maximum loss | -10.91% | -10.91% | -15.44% | -28.30% | - |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,921.4600 | +2.25% | -0.61% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 208.1400 | +4.41% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 1,926.8199 | -0.03% | -7.54% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,092.0100 | +4.68% | +11.74% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,227.6599 | +1.41% | +9.02% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 339.6200 | +2.10% | +12.77% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 306.8900 | +5.38% | +14.35% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 188.5900 | -1.74% | -8.61% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,723.8101 | +3.10% | +2.15% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 140.0100 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 561.0800 | +1.57% | -2.32% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,257.0898 | +2.13% | -0.98% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 184.9100 | -0.21% | -7.67% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 192.7000 | +0.65% | -5.40% | |
| Candriam Equities L Biotech.R US... | reinvestment | 249.9000 | +2.84% | +1.38% | |
| Candriam Equities L Biotech.C US... | reinvestment | 787.3900 | +1.95% | -1.07% | |
| Candriam Equities L Biotech.C US... | paying dividend | 723.3100 | +1.92% | -1.17% |
Performance
| YTD | -4.48% | ||
|---|---|---|---|
| 6 Months | +14.03% | ||
| 1 Year | +3.10% | ||
| 3 Years | +2.15% | ||
| 5 Years | - | ||
| Since start | +14.92% | ||
| Year | |||
| 2023 | +8.38% | ||
| 2022 | -0.47% | ||
| 2021 | -1.66% | ||
